Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 13, 2019 3:23am
111 Views
Post# 29916411

RE:News a must

RE:News a must
fredgoodwinson wrote: and an easy open Goal for management to right the sp in this short but most critical window of time.

Even if not the first patient enrolled they will have a LOAD of positive news on Rutherrin (on which they have told us nothing through years of preclinical research) their Vaccine,Cannabinoid,immune response,Warburg Reversal,etc.etc. On all of these after such long silence they must now have a great deal with which to update us.

Where is the new CEO and WHAT IF ANYTHING IS HE DOING? - get that news out now.




Agree, what is the most important thing to do is to get the long scheduled Phase 2 patient treatment news out...,but the pimp management seems put too much concentration and efforts on this dirty low level PP, ever since this January, withdraw and then push out,then another round of withdraw and push out, then the 3rd time... what an idiot management style... , but for the most important Phase 2 trial start date, we didn't see the pimp management put the same efforts to make it happen ASAP....
Bullboard Posts